Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ames

Showing results (211-220 of 335) with videos related to

Pageof 34
Sort By:
Elife|July 23, 2020
Genetic and environmental determinants of variation in the plasma lipidome of older Australian twinsMatthew Wk Wong, Anbupalam Thalamuthu, Nady Braidy, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2012
Rapid decline in episodic memory in healthy older adults with high amyloid-βYen Ying Lim, Robert H Pietrzak, Kathryn A Ellis, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's DiseaseNawaf Yassi, Saima Hilal, Ying Xia, et al.
Neuropsychologia|September 30, 2015
Investigating the influence of KIBRA and CLSTN2 genetic polymorphisms on cross-sectional and longitudinal measures of memory performance and hippocampal volume in older individualsC J Boraxbekk, David Ames, Nicole A Kochan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2017
Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illnessKarra D Harrington, Yen Ying Lim, David Ames, et al.
Journal of Affective Disorders|January 13, 2018
Amyloid burden and incident depressive symptoms in preclinical Alzheimer's diseaseStephanie Perin, Karra D Harrington, Yen Ying Lim, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 34

Showing results (211-220 of 335) with videos related to

Sort By:
Pageof 34
Elife|July 23, 2020
Genetic and environmental determinants of variation in the plasma lipidome of older Australian twinsMatthew Wk Wong, Anbupalam Thalamuthu, Nady Braidy, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2012
Rapid decline in episodic memory in healthy older adults with high amyloid-βYen Ying Lim, Robert H Pietrzak, Kathryn A Ellis, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's DiseaseNawaf Yassi, Saima Hilal, Ying Xia, et al.
Neuropsychologia|September 30, 2015
Investigating the influence of KIBRA and CLSTN2 genetic polymorphisms on cross-sectional and longitudinal measures of memory performance and hippocampal volume in older individualsC J Boraxbekk, David Ames, Nicole A Kochan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2017
Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illnessKarra D Harrington, Yen Ying Lim, David Ames, et al.
Journal of Affective Disorders|January 13, 2018
Amyloid burden and incident depressive symptoms in preclinical Alzheimer's diseaseStephanie Perin, Karra D Harrington, Yen Ying Lim, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 34